Historical Stock Price
GEVA historical stock prices picture
GEVA (GEVA) has the following price history information. Looking back at GEVA historical stock prices for the last five trading days, on June 17, 2015, GEVA opened at $229.53, traded as high as $232.50 and as low as $228.50, and closed at $231.74. Trading volume was a total of 451.40K shares. On June 18, 2015, GEVA opened at $231.70, traded as high as $236.22 and as low as $231.70, and closed at $235.37. Trading volume was a total of 1.07M shares. On June 19, 2015, GEVA opened at $235.39, traded as high as $237.32 and as low as $233.80, and closed at $235.80. Trading volume was a total of 2.76M shares. On June 22, 2015, GEVA opened at $236.64, traded as high as $239.20 and as low as $236.43, and closed at $238.60. Trading volume was a total of 2.15M shares. On June 23, 2015, GEVA opened at $238.60, traded as high as $238.60 and as low as $238.60, and closed at $238.60. Trading volume was a total of 0 shares.

GEVA Historical Stock Prices By Date:

GEVA historical cagr picture

Below, we examine the compound annual growth rate — CAGR for short — of an investment into GEVA shares, starting with a $10,000 purchase of GEVA, and working forward through the historical stock price information to today.

Growth of $10,000.00
Without Dividends Reinvested

Start date: 04/01/2014
End date: 06/23/2015
Start price/share: $83.34
End price/share: $238.60
Dividends collected/share: $0.00
Total return: 186.30%
Average Annual Total Return: 135.60%
Starting investment: $10,000.00
Ending investment: $28,629.05
Years: 1.23
Date Open High Low Close Volume
06/17/2015 $229.53 $232.50 $228.50 $231.74 451.40K
06/18/2015 $231.70 $236.22 $231.70 $235.37 1.07M
06/19/2015 $235.39 $237.32 $233.80 $235.80 2.76M
06/22/2015 $236.64 $239.20 $236.43 $238.60 2.15M
06/23/2015 $238.60 $238.60 $238.60 $238.60 0
Synageva BioPharma is a biopharmaceutical company focused on the discovery, development, and commercialization of therapeutic products for patients with rare diseases. Co.'s pipeline programs are enzyme replacement therapies for lysosomal storage diseases (LSDs). Co.'s lead program, sebelipase alfa, is in global Phase 3 clinical investigation for the treatment of infants, children and adults with lysosomal acid lipase deficiency, a disease that causes morbidity and mortality. In addition, Co. has several other ongoing research programs at different stages of preclinical development, including SBC-103, another enzyme replacement therapy for an LSD known as mucopolysaccharidosis type IIIB.
Date Close
06/17/2015$231.74
06/18/2015$235.37
06/19/2015$235.80
06/22/2015$238.60
06/23/2015$238.60
GEVA is categorized under the Healthcare sector; below are some other companies in the same sector:

GHDX Historical Stock Prices
GI Historical Stock Prices
GILD Historical Stock Prices
GIVN Historical Stock Prices
GKOS Historical Stock Prices
GLYC Historical Stock Prices
GMED Historical Stock Prices
GNCA Historical Stock Prices
GNMK Historical Stock Prices
GNMX Historical Stock Prices

Email EnvelopeFree GEVA Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts


GEVA Historical Stock Prices | www.HistoricalStockPrice.com | Copyright © 2013 - 2024, All Rights Reserved

Nothing in www.HistoricalStockPrice.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. Split history database is not guaranteed to be complete or free of errors. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Service. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.
X
Wait! Don't leave yet.
Want to receive our latest research absolutely free?


Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 9.5%—Every Month—Forever.

You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 9.5%.